Vapotherm Investor Relations Material
Latest events
Q3 2023
Vapotherm
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Vapotherm Inc
Access all reports
Vapotherm Inc develops and manufactures respiratory care devices, specializing in high-velocity nasal insufflation therapy for patients with respiratory distress. The company markets its products to hospitals and other acute care settings. The company is headquartered in Exeter, New Hampshire, and its shares are listed on the NYSE.
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
VAPO
Country
🇺🇸 United States